Clinical Trials in Houston

Showing 3201-3220 of 15,366 trials

Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas

NCT07215611

To learn about the financial stress patients undergoing surgery to treat orthopedic cancer experience because of the costs of cancer care, and to learn about the effects of financial stress on participants quality of life.

Bone SarcomasFinancial Toxicity

M.D. Anderson Cancer Center100 participantsStarted Sep 2025

Houston, Texas, United States

Enrolling By InvitationNA< 1 mile

Effects of Long-Duration Spaceflight on General and Spatial Cognition and Its Neural Basis

NCT04856410

This study investigates the effects of extended-duration spaceflight (12-month International Space Station missions) on general cognitive performance (measured with the Cognition test battery), spatial cognition, structural and functional brain changes in general, and hippocampal plasticity more specifically relative to the shorter 6-month and 2-month missions.

Brain StructureCognitive Performance

University of Pennsylvania14 participantsStarted Aug 2021

Philadelphia, Pennsylvania, United States • Houston, Texas, United States • Berlin, Germany

COMPLETEDPhase 1< 1 mile

Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma

NCT04169711

The purpose of this study is to evaluate the safety and efficacy of ARO-HIF2 injection (also referred to as ARO-HIF2) and to determine the recommended Phase 2 dose in the treatment of patients with advanced clear cell renal cell carcinoma (ccRCC).

Clear Cell Renal Cell Carcinoma

Arrowhead Pharmaceuticals26 participantsStarted Aug 2020

Aurora, Colorado, United States • Las Vegas, Nevada, United States • Nashville, Tennessee, United States +2 more locations

Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas

Effects of Long-Duration Spaceflight on General and Spatial Cognition and Its Neural Basis

Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma

Find Trials by Condition in Houston

Extension of Phase 3 Gene Therapy for Painful Diabetic Neuropathy

A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm

A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens

Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma

Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL Mutations

Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder

Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis

Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma

Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters

A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid Tumors

A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread

Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses

Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants

Prospective Clinical Assessment Study in Children With Hypochondroplasia

Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies

A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma